How to write an effective cover letter for journal submission
Most journals require a cover letter with every manuscript submission — yet many authors treat it as a formality. That’s a missed opportunity. A well-crafted cover letter is your first and sometimes only chance to make a case directly to the editor for why your manuscript deserves to be sent out for peer review.
As a Nature Immunology editorial notes, a cover letter “initiates a dialog between the authors and the editors” and “serves to whet the appetite of the editors.”
A hurried, template-filled letter adds little value and can signal to editors that the manuscript itself may not have received careful attention.
This guide covers everything you need: what to include, what to avoid, a worked example, journal-specific tips, and a resubmission cover letter guide.
Why Your Cover Letter Matters More Than You Think
Editors at high-impact journals receive hundreds of submissions. Before a manuscript ever reaches a peer reviewer, it typically passes through editorial prescreening — a rapid assessment of scope, novelty, and expected significance.
According to the RSC Advances editorial team, “most journals (especially high profile / high impact) pre-screen manuscripts on the basis of scope, novelty, originality, and expected impact/relevance/significance of the work. The cover letter is the best opportunity to convince the editor to send your manuscript out for peer review.“
A manuscript rejected at the desk review stage (often within days of submission) may never receive substantive feedback. The cover letter is your defence against that outcome.
What to Include in Your Cover Letter
Use the checklist below as your starting point. Always check your target journal’s Author Guidelines first as some publishers have specific requirements that override general advice.
| Element | What to write | Required? |
| Title of manuscript | Full title as it appears in the submission | Always |
| Corresponding author details | Name, affiliation, email, and phone | Always |
| Summary of findings | 3–4 sentences: the problem, your approach, key result, and significance. No jargon | Always |
| Journal fit | One sentence linking your work to the journal’s scope and readership | Always |
| Originality statement | Confirm the manuscript is original and not under consideration elsewhere | Always |
| Author agreement | Confirm all authors have read and approved the submission | Always |
| Ethical approval | IRB/ethics committee approval number; for clinical trials, informed consent statement and registration number | If applicable |
| Conflict of interest | Disclose any potential conflicts, or explicitly state there are none | Always |
| Preferred / non-preferred reviewers | Suggest 2–3 reviewers with no conflicts; list any who should be excluded and why | If permitted |
| Prior editor contact | Note any prior expression of interest from an editor (conference, social media) | If applicable |
| Related concurrent submissions | List any related papers by co-authors under review elsewhere | If applicable |
| Fast-track request | Request expedited review only if you have genuine evidence of competing work | Use sparingly |
Writing a compelling summary of your findings
Your summary is the most important part of the cover letter. It should answer four questions in 3–4 sentences:
- What gap or problem does this study address?
- What did you do (briefly)?
- What is the key finding?
- Why does it matter to the field and to this journal’s readers?
Avoid copying your abstract directly. Instead, place your findings in the context of the current literature. Ask yourself: Does this paper refute, complement, or substantially extend a key result in the field? If yes, say so explicitly.
RSC’s editorial guidance advises authors to write “BOTH for the expert (e.g. referee) AND for an interested reader working in an adjacent area.” This is especially important for high-impact generalist journals where appeal to non-specialists is explicitly evaluated.
What to Avoid: Common Mistakes
Editors can identify a weak cover letter within seconds. The following mistakes are the most common.
| Mistake | Why it’s a problem | What to do instead |
| Copying the abstract verbatim | The abstract is already in the manuscript. A copy adds nothing and signals minimal effort. | Write a fresh 3–4 sentence narrative that contextualises findings within the literature. |
| Generic / template language | Phrases like ‘We believe this paper will be of great interest’ are meaningless without specifics. | Name the journal’s recent relevant papers or describe the specific readership that will benefit. |
| Listing author credentials | Editors evaluate the manuscript, not the CV. | Let the quality of the science speak; briefly mention methodology only if it’s the novelty. |
| Excessive length | Editors read dozens of letters a day; more than one page signals poor editing judgement. | Keep the body to 3–5 short paragraphs. Total length: under one page. |
| Too much jargon | The handling editor may not be a specialist in your exact subfield. | Use clear, accessible language. Save technical detail for the manuscript. |
| Wrong journal name | Sending a letter addressed to Journal X to Journal Y is an immediate red flag. | Use a checklist before submission; personalise every letter. |
| Overselling findings | Exaggerated claims damage credibility with expert reviewers. | Let data carry the weight; use measured, precise language. |
| Spelling and grammar errors | Signals carelessness in the manuscript too. | Proofread the letter as carefully as the paper itself. |
RSC Advances shared a real example of a ‘lazy’ template letter that addressed the journal correctly in the greeting but then named a completely different journal in the body — a common and embarrassing error. Always do a final find-and-replace check for any previous journal names before submitting.
A Good Cover Letter: Annotated Example
Below is a short, annotated model letter. Each numbered bracket refers to the checklist element it addresses.
Dear Professor [Editor Name],
[1] We are pleased to submit our manuscript, “Nanoparticle-Enhanced Drug Delivery Across the Blood–Brain Barrier: A Murine Model Study,” for consideration in Journal of Controlled Release.
[2] Despite decades of effort, therapeutic delivery to the central nervous system remains a fundamental challenge: more than 98% of small-molecule drugs fail to cross the blood–brain barrier (BBB). We developed a lipid-coated iron oxide nanoparticle platform guided by low-frequency ultrasound, which achieved a 4.7-fold increase in brain parenchymal drug concentration compared with free drug in a syngeneic glioblastoma mouse model — without detectable systemic toxicity. These findings directly address the translational bottleneck outlined in [recent landmark paper] and suggest a clinically viable route toward CNS-targeted therapy.
[3] Given the journal’s focus on drug delivery mechanisms and translational nanomedicine, we believe this work will resonate with your readership working on CNS therapeutics, oncology, and biomaterials.
[4][5][6] This manuscript has not been published previously and is not under consideration by any other journal. All authors have read and approved this version. This study was approved by the Institutional Animal Care and Use Committee (Protocol #2024-0312). The authors declare no competing interests.
[7] We suggest Professor A. Smith (Stanford) and Dr B. Patel (UCL) as reviewers due to their expertise in CNS drug delivery. We request that Dr C. Jones (MIT) be excluded owing to an existing conflict of interest.
Yours sincerely, [Corresponding Author Name, Affiliation, Email, Phone]
Key: [1] Title and journal name | [2] Summary with literature context | [3] Journal fit | [4] Originality | [5] Author agreement | [6] Ethics/COI | [7] Reviewer suggestions
Adapting Your Letter by Publisher and Journal Type
Publisher requirements and editorial culture vary significantly. The table below summarises key differences to be aware of.
| Journal type | Key adaptation | Watch out for |
| High-impact generalists (e.g. Nature, Science, NEJM) | Emphasise broad societal significance; appeal to non-specialist editors explicitly. Novelty must be immediate and clear. | Do not lead with technical detail. State the advance in one sentence a non-specialist can evaluate. |
| Specialist / society journals (e.g. ACS Nano, Gut) | Show deep knowledge of the field; cite recent relevant papers in the journal itself. | Scope mismatch is the top desk-rejection reason. Confirm your topic maps directly to the journal’s aims. |
| Open-access mega-journals (e.g. PLOS ONE, Scientific Reports) | These journals evaluate scientific soundness over novelty. Stress rigour and reproducibility. | Novelty-based arguments are less relevant; focus on methodological integrity. |
| Clinical journals (e.g. BMJ, JAMA, The Lancet) | Include IRB approval, trial registration number, and informed consent statement explicitly in the letter. | BMJ also asks for any previous reviews or editor communications as supplementary files; these can expedite review. |
| Elsevier journals | Check the individual journal’s Guide for Authors. Elsevier’s platform (Editorial Manager) often has specific required fields that go beyond the cover letter. | Conflict of interest, funding, and reviewer suggestions are frequently captured in separate system fields. Do not omit from the letter unless the guide says so. |
Tip: Always read the target journal’s most recent 3–5 editorial/opinion pieces before writing. Referencing a specific paper the journal recently published (and explaining how yours builds on or contrasts with it) is one of the most effective ways to demonstrate fit.
Writing a Resubmission Cover Letter After Peer Review
A resubmission letter after peer review is a distinct document from your initial cover letter. It has a different purpose, audience, and structure.
Structure of a resubmission letter
- Opening: Thank the editor and reviewers for their time. Reference the manuscript ID and title.
- Overall response: State briefly whether you have accepted all reviewer comments or whether you have respectfully disagreed with any, and why.
- Summary of major changes: List 3–5 key revisions you made, cross-referencing the reviewer comment they address.
- Statement on unchanged content: If you have not made a requested change, provide a clear, evidence-based justification.
- Closing: Confirm the revised manuscript has not been submitted elsewhere.
Note: A detailed, point-by-point response to reviewers should be submitted as a separate Response to Reviewers document and not embedded in the cover letter. The cover letter is a brief summary; the response document is the full record.
BMJ specifically encourages authors to attach previous editors’ comments, their responses, and any previous reviewers’ comments as “Supplementary files for editors only.” This transparency can meaningfully speed up the review cycle.
Frequently Asked Questions
Do I always need to submit a cover letter?
Not always, some journals mark it as optional. However, even when optional, a well-written letter is almost always worth including. Check the journal’s Author Guidelines before assuming it is required.
How long should a cover letter for a journal submission be?
No longer than one page. Aim for 3–5 focused paragraphs. Editors read many letters daily; brevity combined with specificity is the goal.
What is the difference between a cover letter and an abstract?
The abstract is a technical summary of your study for specialist readers. The cover letter is a persuasive pitch aimed at the editor, explaining why the manuscript belongs in this specific journal and why readers will care. Never copy-paste one into the other.
Can I suggest reviewers in a cover letter?
Yes, and most journals encourage it. Suggest 2–3 experts with relevant knowledge who have no conflicts of interest with you or your co-authors. You can also nominate reviewers to be excluded. The editor retains full discretion.
What should I include in a cover letter for a clinical trial manuscript?
Include the IRB/ethics committee approval number, the clinical trial registration number (e.g. ClinicalTrials.gov), and confirmation that informed consent was obtained from all participants.
What should a resubmission cover letter say?
Thank the editor and reviewers, briefly summarise the major revisions you have made, and note any points of respectful disagreement with reviewers (with justification). Direct the editor to your separate Response to Reviewers document for the full point-by-point reply.
Cover Letter Checklist: Before You Submit
- Manuscript title and all author/contact details included
- 3–4 sentence summary written fresh (not copied from the abstract)
- Findings placed in context of relevant literature
- Journal fit explained explicitly — scope, readership, or recent papers cited
- Originality and no-concurrent-submission statement included
- All authors confirmed as having read and approved the submission
- Ethical approval/IRB number included (if applicable)
- Conflict of interest disclosed or explicitly stated as none
- Preferred and non-preferred reviewers listed (if the journal permits)
- Correct journal name appears throughout — no copy-paste errors
- Language is clear and free of excessive jargon
- Total length is one page or less
- Spelling and grammar proofread
- Letter is formatted cleanly (standard font, consistent spacing)
Editor’s Note: This post was originally published in 2013 and has been refreshed in 2018 and on May 16, 2026.
Cover Letter Template for Journal Submissions.pdf
